Cargando…
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
The occurrence of epileptic seizures in the presence of hepatic disease is not uncommon in clinical practice. Selecting an appropriate AED for patients affected by liver failure who have new-onset epileptic seizures can be challenging. We describe a 64-year-old man affected by liver cirrhosis. The p...
Autores principales: | Romigi, A., Placidi, F., Liguori, C., Izzi, F., Marchi, A., Tarquini, E., Albanese, M., Mercuri, N.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308026/ https://www.ncbi.nlm.nih.gov/pubmed/25667897 http://dx.doi.org/10.1016/j.ebcr.2014.08.003 |
Ejemplares similares
-
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018) -
Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
por: Liu, Wenyu, et al.
Publicado: (2023) -
Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023) -
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019) -
Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy
por: Calvello, Carmen, et al.
Publicado: (2023)